While genetic mutations in oncogenes and TSGs such as TP53 and CTNNB1 are well-established in HCC [8], recent advances underscore the pivotal role of epigenetic dysregulation in liver carcinogenesis [9]. The gene discussed is TP53; the disease is hepatocellular carcinoma.